- $506.68m
- $306.17m
- $228.39m
- 86
- 57
- 99
- 96
Annual income statement for CryoPort, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 78.7 | 223 | 237 | 233 | 228 |
| Cost of Revenue | |||||
| Gross Profit | 36.3 | 96.6 | 104 | 99.3 | 99.6 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 109 | 492 | 269 | 343 | 341 |
| Operating Profit | -30 | -270 | -31.9 | -109 | -112 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -32.7 | -274 | -35.1 | -99.3 | -113 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -32.7 | -276 | -37.3 | -99.6 | -115 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -32.7 | -276 | -37.3 | -99.6 | -115 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -75 | -284 | -45.3 | -108 | -123 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.94 | -2.63 | -0.897 | -1.53 | -1.85 |